{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:23:57Z","timestamp":1790717037718,"version":"4.1.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100016421","name":"Cardiovascular Medical Research and Education Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016421","name":"Cardiovascular Medical Research and Education Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016421","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016421","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) cause right ventricular dysfunction, which can impact other solid organs. However, the profiles and consequences of hepatic injury resulting from PAH and CTEPH have not been well studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We aimed to identify underlying patterns of liver injury in a cohort of patients with PAH and CTEPH enrolled in 15 randomized clinical trials conducted between 1998 and 2014.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used unsupervised machine learning to identify liver injury clusters in 13 trials and validated the findings in two additional trials. We then determined whether these liver injury clusters were associated with clinical outcomes or treatment effect heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Our training dataset included 4,219 patients and our validation dataset included 1,756 patients with serum total bilirubin, alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, and albumin data. Using k-means clustering, we identified phenotypes with no liver injury, hepatocellular injury, cholestatic injury, and combined injury patterns. Patients in the cholestatic injury liver cluster had the shortest time to clinical worsening and the highest risk of mortality. The cholestatic injury group also experienced the greatest placebo-corrected treatment effect on 6-minute-walk distance. Randomization to the experimental arm transitioned patients to a healthier liver status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Liver injury was associated with adverse outcomes in patients with PAH and CTEPH. Randomization to active treatment had beneficial effects on liver health compared with placebo. The role of liver disease (often subclinical) in determining outcomes warrants prospective studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.202311-2196oc","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T14:47:23Z","timestamp":1717166843000},"page":"1045-1056","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":16,"title":["Novel Liver Injury Phenotypes and Outcomes in Clinical Trial Participants with Pulmonary Hypertension"],"prefix":"10.1093","volume":"210","author":[{"given":"Jacqueline V.","family":"Scott","sequence":"first","affiliation":[{"name":"Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jude","family":"Moutchia","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin L.","family":"McClelland","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Washington, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Al-Naamani","sequence":"additional","affiliation":[{"name":"Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Weinberg","sequence":"additional","affiliation":[{"name":"Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold I.","family":"Palevsky","sequence":"additional","affiliation":[{"name":"Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7864-6096","authenticated-orcid":false,"given":"Jasleen","family":"Minhas","sequence":"additional","affiliation":[{"name":"Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina K.","family":"Appleby","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akaya","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Pugliese","sequence":"additional","affiliation":[{"name":"Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey E.","family":"Ventetuolo","sequence":"additional","affiliation":[{"name":"Department of Medicine and"},{"name":"Department of Health Services, Policy and Practice, Brown University, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Kawut","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics and"},{"name":"Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,15]]},"reference":[{"key":"2026031604124605500_bib1","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/CIRCULATIONAHA.116.022362","article-title":"Systemic consequences of pulmonary hypertension and right-sided heart failure","volume":"141","author":"Rosenkranz","year":"2020","journal-title":"Circulation"},{"key":"2026031604124605500_bib2","doi-asserted-by":"crossref","first-page":"1900625","DOI":"10.1183\/13993003.00625-2019","article-title":"Vena cava backflow and right ventricular stiffness in pulmonary arterial hypertension","volume":"54","author":"Marcus","year":"2019","journal-title":"Eur Respir J"},{"key":"2026031604124605500_bib3","doi-asserted-by":"crossref","first-page":"20458940211054304","DOI":"10.1177\/20458940211054304","article-title":"Liver abnormalities in pulmonary arterial hypertension","volume":"11","author":"Nickel","year":"2021","journal-title":"Pulm Circ"},{"key":"2026031604124605500_bib4","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"2026031604124605500_bib5","first-page":"A5304","article-title":"Unsupervised machine learning for identification of cardiohepatic syndrome in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension [abstract]","volume":"205","author":"Scott","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2026031604124605500_bib6","author":"Scott","year":"2023"},{"key":"2026031604124605500_bib7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1183\/09031936.00194810","article-title":"Liver toxicity of sitaxentan in pulmonary arterial hypertension","volume":"37","author":"Gali\u00e8","year":"2011","journal-title":"Eur Respir J"},{"key":"2026031604124605500_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0041-1739361","article-title":"A semi-automated term harmonization pipeline applied to pulmonary arterial hypertension clinical trials","volume":"61","author":"Urbanowicz","year":"2022","journal-title":"Methods Inf Med"},{"key":"2026031604124605500_bib9","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1513\/AnnalsATS.202110-1139OC","article-title":"Secular and regional trends among pulmonary arterial hypertension clinical trial participants","volume":"19","author":"Min","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"2026031604124605500_bib10","first-page":"121","author":"Edy","year":"2020"},{"key":"2026031604124605500_bib11","first-page":"40","article-title":"Application of factor analysis to k-means clustering algorithm on transportation data","volume":"95","author":"Sesham","year":"2014","journal-title":"Int J Comput Appl"},{"key":"2026031604124605500_bib12","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijcard.2016.11.036","article-title":"Direct bilirubin: a new risk factor of adverse outcome in idiopathic pulmonary arterial hypertension","volume":"228","author":"Xu","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026031604124605500_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2466-10-22","article-title":"Bilirubin as a prognostic marker in patients with pulmonary arterial hypertension","volume":"10","author":"Takeda","year":"2010","journal-title":"BMC Pulm Med"},{"key":"2026031604124605500_bib14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"},{"key":"2026031604124605500_bib15","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.healun.2011.03.011","article-title":"Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials","volume":"30","author":"Benza","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"2026031604124605500_bib16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.amjcard.2004.09.006","article-title":"New predictors of outcome in idiopathic pulmonary arterial hypertension","volume":"95","author":"Kawut","year":"2005","journal-title":"Am J Cardiol"},{"key":"2026031604124605500_bib17","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCHEARTFAILURE.110.949933","article-title":"Characteristics and outcome after hospitalization for acute right heart failure in patients with pulmonary arterial hypertension","volume":"4","author":"Haddad","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2026031604124605500_bib18","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/clc.22954","article-title":"Serum albumin concentration as an independent prognostic indicator in patients with pulmonary arterial hypertension","volume":"41","author":"Snipelisky","year":"2018","journal-title":"Clin Cardiol"},{"key":"2026031604124605500_bib19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/00365513.2023.2225778","article-title":"Cardiohepatic syndrome and its prognostic predictive ability in patients with pulmonary arterial hypertension","volume":"83","author":"Sungur","year":"2023","journal-title":"Scand J Clin Lab Invest"},{"key":"2026031604124605500_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.healun.2021.09.005","article-title":"Magnetic resonance relaxometry of the liver \u2013 a new imaging biomarker to assess right heart failure in pulmonary hypertension","volume":"41","author":"Bogaert","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"2026031604124605500_bib21","doi-asserted-by":"crossref","first-page":"e026254","DOI":"10.1161\/JAHA.122.026254","article-title":"Prognostic value of hepatic native T1 and extracellular volume fraction in patients with pulmonary arterial hypertension","volume":"11","author":"Guo","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026031604124605500_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132189","article-title":"Native hepatic T1-time as a non-invasive predictor of diastolic dysfunction and a monitoring tool for disease progression and treatment response in patients with pulmonary hypertension","volume":"409","author":"Kremer","year":"2024","journal-title":"Int J Card"},{"key":"2026031604124605500_bib23","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.healun.2024.02.013","article-title":"Liver stiffness is associated with right heart dysfunction, cardiohepatic syndrome, and prognosis in pulmonary hypertension","volume":"43","author":"Rako","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"2026031604124605500_bib24","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.jacc.2013.03.042","article-title":"Cardiohepatic interactions in heart failure: an overview and clinical implications","volume":"61","author":"Samsky","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026031604124605500_bib25","doi-asserted-by":"crossref","first-page":"2101454","DOI":"10.1183\/13993003.01454-2021","article-title":"Right atrial function is associated with right venticular diastolic stiffness: RA-RV interaction in pulmonary arterial hypertension","volume":"59","author":"Wessels","year":"2022","journal-title":"Eur Respir J"},{"key":"2026031604124605500_bib26","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jacc.2023.05.063","article-title":"Right atrial adaptation to precapillary pulmonary hypertension: pressure-volume, cardiomyocyte, and histological analysis","volume":"82","author":"Wessels","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026031604124605500_bib27","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1378\/chest.08-1758","article-title":"Determinants of right ventricular ejection fraction in pulmonary arterial hypertension","volume":"135","author":"Kawut","year":"2009","journal-title":"Chest"},{"key":"2026031604124605500_bib28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.healun.2021.11.004","article-title":"Interplay of sex hormones and long-term right ventricular adaptation in a Dutch PAH-cohort","volume":"41","author":"van Wezenbeek","year":"2022","journal-title":"J Heart Lung Transplant"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/210\/8\/1045\/67365753\/ajrccm_210_8_1045.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/210\/8\/1045\/67365753\/ajrccm_210_8_1045.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T08:12:56Z","timestamp":1773648776000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/210\/8\/1045\/8491342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":28,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,10,15]]},"published-print":{"date-parts":[[2024,10,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.202311-2196oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"2023-11-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}